Literature DB >> 36119831

Multi-omics characterization of the unsaturated fatty acid biosynthesis pathway in colon cancer.

Ling Chen1, Chang-Shun Yang2, Si-Dong Chen3, Qiao-Xia Zhou3, Guo-Qiang Wang3, Shang-Li Cai3, Wei-Hua Li2, Hong-Zhi Luo4.   

Abstract

The biosynthesis of unsaturated fatty acids is involved in the initiation and progression of colon adenocarcinoma (COAD). In this study, we aimed to investigate the multi-omics characteristics of unsaturated fatty acid biosynthesis-related genes and explore their prognostic value in colon cancer by analyzing the data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. An unsaturated fatty acid biosynthesis pathway related-genes enrichment score (BUFAS) was constructed utilizing the single sample gene set enrichment analysis (ssGSEA). We discovered that a high BUFAS was associated with longer overall survival (OS) in both the training and the validation sets. Multivariable analysis including the clinical characteristics further verified the independent prognostic value of the BUFAS in both the TCGA-COAD and the GSE39582 datasets. In addition, GSEA analysis revealed that BUFAS was positively associated with several signaling pathways, including MTORC1, peroxisome, and pathways related to fatty acid metabolism, while was negatively associated with other signaling pathways, such as hedgehog, NOTCH, and Wnt/beta-catenin pathway. Furthermore, in the COAD cell lines of the Genomics of Drug Sensitivity in Cancer (GDSC) database, we found that BUFAS was positively correlated with the drug sensitivities of cisplatin, gemcitabine, camptothecin, lapatinib, and afatinib, while was negatively correlated with that of ponatinib. Moreover, in the COAD single-cell transcriptomic dataset (GSE146771), the BUFAS varied among different cell types and was enriched in mast cells and fibroblasts. Taken together, the BUFAS we constructed could be used as an independent prognostic signature in predicting the OS and drug resistance of colon cancer. Unsaturated fatty acid biosynthesis pathway might serve as potential therapeutic targets for cancer treatment. AJCR
Copyright © 2022.

Entities:  

Keywords:  Unsaturated fatty acids biosynthesis; colon cancer; multi-omics characterization; overall survival; prognostic signature

Year:  2022        PMID: 36119831      PMCID: PMC9442000     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   5.942


  63 in total

Review 1.  Omega-3 fatty acids in inflammation and autoimmune diseases.

Authors:  Artemis P Simopoulos
Journal:  J Am Coll Nutr       Date:  2002-12       Impact factor: 3.169

2.  Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis.

Authors:  Eva Cífková; Michal Holčapek; Miroslav Lísa; David Vrána; Jiří Gatěk; Bohuslav Melichar
Journal:  Anal Bioanal Chem       Date:  2014-10-29       Impact factor: 4.142

3.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

4.  Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells.

Authors:  Feng-Yao Tang; Hsin-Ju Cho; Man-Hui Pai; Ye-Hsin Chen
Journal:  J Nutr Biochem       Date:  2008-08-15       Impact factor: 6.048

5.  FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism.

Authors:  Chunyu Zhang; Yuandong Liao; Pan Liu; Qiqiao Du; Yanchun Liang; Shiyin Ooi; Shuhang Qin; Shanyang He; Shuzhong Yao; Wei Wang
Journal:  Theranostics       Date:  2020-05-17       Impact factor: 11.556

6.  A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer.

Authors:  Rui Zhou; Dongqiang Zeng; Jingwen Zhang; Huiying Sun; Jianhua Wu; Nailin Li; Li Liang; Min Shi; Jianping Bin; Yulin Liao; Na Huang; Wangjun Liao
Journal:  EBioMedicine       Date:  2019-03-24       Impact factor: 8.143

7.  The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy.

Authors:  Rob Ofman; Inge M E Dijkstra; Carlo W T van Roermund; Nena Burger; Marjolein Turkenburg; Arno van Cruchten; Catherine E van Engen; Ronald J A Wanders; Stephan Kemp
Journal:  EMBO Mol Med       Date:  2010-03       Impact factor: 12.137

8.  WGCNA: an R package for weighted correlation network analysis.

Authors:  Peter Langfelder; Steve Horvath
Journal:  BMC Bioinformatics       Date:  2008-12-29       Impact factor: 3.169

9.  Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition.

Authors:  Giada Gelsomino; Paola A Corsetto; Ivana Campia; Gigliola Montorfano; Joanna Kopecka; Barbara Castella; Elena Gazzano; Dario Ghigo; Angela M Rizzo; Chiara Riganti
Journal:  Mol Cancer       Date:  2013-11-13       Impact factor: 27.401

10.  Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.

Authors:  Ying Qi; Di Chen; Qiqi Lu; Yu Yao; Chunxia Ji
Journal:  Dis Markers       Date:  2019-12-04       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.